echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > SCI SIGNAL: What do cancer cells with oxidizing phosphorylation defects survive?

    SCI SIGNAL: What do cancer cells with oxidizing phosphorylation defects survive?

    • Last Update: 2020-07-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    !---- existing studies have shown that spontaneous Ca2-plus signal conduction from the Ca2-plus release channel within InsP3R cells to the mitochondria is essential for the production of optimal oxyped phosphorylation (OXPHOS) and ATPin cells with OXPHOS defects, reductive carnitination replaces oxidation metabolism to maintain the reduction equivalent and the number of metabolic precursorsto study the role of mitochondrial Ca2 plus ingesting in regulating biological energy in these cells, the researchers used oxPHOS cells with function and OXPHOS defectsinhibition of InsP3R activity or mitochondrial Ca2 plus intake increases the abundance of alpha-ketone diacid (alphaKG) and the NAD-NADH ratio, indicating that the constituent endosome(ER)-mitochondrial Ca2-plus transfer promotes the optimal activity of alpha-kgdease (alpha KGDH)reducemidrop mitochondrial Ca2 plus inhibits alpha KGDH activity and increases NAD plus, thereby inducing SIRT1-dependent autophagy, a phenomenon that is present in OXPHOS-competent and OXPHOS-defective cellsautophagy flux in OXPHOS-competent cells promotes cell survival, while autophagy flux is impaired in OXPHOS-defective cells due to inhibition of autophagy-lysosome fusionin OXPHOS defective cells, the inhibition of alpha KGDH and the loss of autophagy flux lead to cell death in response to the interruption of the constituent flux from Ca2 plus to mitochondrialthese results show that mitochondria play a fundamental role in maintaining the bioenergy balance of OXPHOS sound cells and OXPHOS defective cells, in which Ca2 plus plays a key role in regulating alpha KGDH activityinhibition of Ca2-plus metastasis from ER to mitochondria may be a common treatment for cancer cells, regardless of their OXPHOS status.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.